INI-4001
INI-4001 has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 28, 2025: “Elicitation of protective immune responses against influenza a viruses in elderly ferrets by adjuvanted recombinant universal influenza hemagglutinin vaccines”.
At a glance
1 trial, none about aging.
Cells, worms or flies, mice and humans: nothing yet.
- 1 trial, none about aging
- 1 of 1 trial sponsored by its developers
- Animals1
Who is developing INI-4001?
1 company: Inimmune.
- Companies
- InimmunePhase 1advanced solid tumor
Trial sponsors
Company1 trialPhase 110 people